fajgenbaum in A Sentence

    1

    Fajgenbaum fell into this group.

    0
    2

    Fajgenbaum hypothesized that a drug that inhibited this pathway may help with his condition.

    0
    3

    Fajgenbaum assumed that a drug that inhibits this pathway may help with his condition.

    0
    4

    Fajgenbaum has not had a flare-up of symptoms since he started taking the drug in 2014.

    0
    5

    But by studying his own blood tests, Fajgenbaum identified a possible clue to his illness.

    0
    6

    But by studying his own blood samples, Fajgenbaum identified a possible clue to his illness.

    0
    7

    Fajgenbaum was eventually diagnosed with Castleman's disease, which is actually a group of inflammatory disorders affecting the lymph nodes.

    0
    8

    The doctor's assignment began in 2010, when Fajgenbaum, who was then an athletic 25-year-old in medical school suddenly became ill.

    0
    9

    The doctor's quest began in 2010, when Fajgenbaum, who was then an athletic 25-year-old in medical school, suddenly fell ill.

    0
    10

    Soon Fajgenbaum and colleagues plan to start a clinical trial to test sirolimus in up to 24 patients with iMCD.

    0
    11

    Fajgenbaum was eventually diagnosed with Castleman disease, which is actually a group of inflammatory disorders that affect the lymph nodes.

    0
    12

    Fajgenbaum has this more serious form, known as idiopathic multicentric Castleman's disease(iMCD), which is diagnosed in only 1,500 to 1,800 Americans each year, according to the report.

    0
    13

    Fajgenbaum has this more severe form, known as idiopathic multicentric Castleman disease(iMCD), which is diagnosed in only about 1,500 to 1,800 Americans each year, according to the report.

    0
    14

    In the new study, Fajgenbaum and colleagues report that two other patients with iMCD also showed increased levels of activated T cells and VEGF-A before their symptoms flared up.

    0
    15

    The work, published today(Aug. 13) in the Journal of Clinical Investigation, is one of the few occasions when the lead author of the report(Fajgenbaum) is also a patient in the study.

    0